FDA warns of risks of xylazine in illicit drugs




  • In Health
  • 2022-11-08 21:14:35Z
  • By CBS News
 

The Food and Drug Administration released an alert Tuesday warning health care professionals to be "cautious" of an animal medication that has entered the illegal drug supply and been identified in overdoses.

The medication, xylazine, has been FDA-approved to use as an animal sedative and pain reliever. It has no approved use for humans and can cause "serious and life-threatening side effects that appear to be similar to those commonly associated with opioid use."

In a letter to stakeholders, the FDA said that xylazine was most often found in combination with opioids like fentanyl or heroin, or occasionally alongside stimulants like methamphetamine or cocaine. The administration warned that people who are exposed to xylazine "may not be aware" that it is present in their drug supply.

The alert warned that it can be "difficult to distinguish" xylazine overdoses from opioid overdose, since some side effects, including respiratory depression, are similar.

Routine toxicology screens also do not detect xylazine. Other side effects can include hypothermia, hypotension, and "severe, necrotic skin ulcerations" caused by repeated exposure to xylazine via injection.

Despite the similar side effects and presentation, xylazine affects the human body differently than opioids do.

"Xylazine knocks (humans) out in a really broad way," said Claire Zagorski, a paramedic and program director and harm reduction instructor with Texas Opioid Training Initiative at the University of Texas at Austin. "It brings down brain activity, slows down heart rate, slows down breathing, but opioids have this special aspect to them where they can really stop breathing. Xylazine doesn't act in quite the same way. … We aren't seeing the kind of sudden fatal overdose like we've been seeing with fentanyl."

The FDA said it is unsure if side effects from xylazine exposure can be reversed by naloxone, a medication that can reverse opioid overdoses, because xylazine is not an opioid.

"(Xylazine overdoses) are almost certainly not reversible with naloxone," said Zagorski, adding that just one study has suggested naloxone working to reverse such an overdose. The study was conducted in chicks in 1984.

Zagorski also warned that fentanyl testing strips, which can check illicit substances for the presence of the powerful opioid, do not work with xylazine. Test strips for xylazine are in development, according to Jeffrey Bratberg, a clinical professor at the University of Rhode Island College of Pharmacy.

Winning $2 billion Powerball ticket sold in Altadena, California

Michigan's secretary of state on reassuring voters of election integrity

Nevada Senate race critical to Democrats' hopes of keeping power in Congress

COMMENTS

More Related News

U.S. FDA says India-made eye drop linked to some infections, blindness and one death
U.S. FDA says India-made eye drop linked to some infections, blindness and one death
  • US
  • 2023-02-03 15:43:24Z

The U.S. Food and Drug Administration has warned against using an India-made eye drop that has been linked to the outbreak of a drug-resistant bacteria...

Gilead
Gilead's breast cancer drug secures U.S. FDA approval for expanded use
  • US
  • 2023-02-03 15:40:15Z

It was approved in patients with an advanced form of breast cancer with subtype known as HR-positive/HER2-negative, who had stopped responding to at least...

FDA faults company behind recalled eye drops for multiple violations
FDA faults company behind recalled eye drops for multiple violations

Global Pharma's eye drops have been linked to a U.S. outbreak which has led to at least five people losing their vision.

Mailing abortion pills could break law, Republican AGs tell pharmacies
Mailing abortion pills could break law, Republican AGs tell pharmacies
  • US
  • 2023-02-02 00:18:10Z

A group of 20 Republican state attorneys general on Wednesday told Walgreens Boots Alliance Inc and CVS Health Corp that they risk running afoul of federal...

U.S. FDA approves GSK
U.S. FDA approves GSK's anemia drug for patients on dialysis
  • US
  • 2023-02-01 23:37:53Z

The drug Jesduvroq comes with the boxed warning for increased thrombotic vascular events, including death, heart attack, stroke, and blood clots in the lungs...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health